MétaCan
Menu
Back to cohort
Record W2803180787 · doi:10.1111/hiv.12607

Prospective plasma efavirenz concentration assessment in Chinese HIV‐infected adults enrolled in a large multicentre study

2018· article· en· W2803180787 on OpenAlexaff
fuping guo, Xinqi Cheng, Evelyn Hsieh, Xiaoli Du, Qiang Fu, Wei Peng, Yinghui Li, X Song, Routy Jp, T Li

Bibliographic record

VenueHIV Medicine · 2018
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsMcGill University Health Centre
FundersFogarty International CenterU.S. Food and Drug AdministrationChinese Academy of Medical Sciences
KeywordsEfavirenzMedicineInterquartile rangeProspective cohort studyDosingInternal medicineGastroenterologyConfidence intervalPharmacokineticsTherapeutic drug monitoringAntiretroviral therapyHuman immunodeficiency virus (HIV)Viral loadVirology

Abstract

fetched live from OpenAlex

Objectives Few studies have explored the optimal dosing for efavirenz in individuals from China. We investigated plasma efavirenz concentrations and their association with efficacy and tolerance of efavirenz 600 mg daily in Chinese HIV‐infected adults. Methods An analysis was performed using plasma samples from 455 patients enrolled in a prospective multicentre trial in China. A total of 1198 plasma samples collected at weeks 4, 24 and 48 following antiretroviral therapy initiation were analysed. The mid‐dose interval efavirenz concentrations ( C 12 ) were determined using high‐performance liquid chromatography. Results The median efavirenz concentration (interquartile range) steadily increased over time from 3.02 (2.28–4.23) to 3.71 (2.91–4.91) mg/L from week 4 to 48 ( P < 0.001). The proportion of patients with C 12 > 4.0 mg/L also rose from 28.0% to 34.2% and 43.8%, measured at 4, 24 and 48 weeks, respectively ( P < 0.001). Five patients had efavirenz concentrations < 1.0 mg/L at week 4, 24 or 48. In the multivariable regression analysis, lower body weight and non‐Han ethnicities were associated with higher efavirenz concentrations over time. At each time‐point, patients with a body weight < 60 kg had significantly higher efavirenz C 12 compared with those with body weight ≥ 60 kg ( P < 0.05). Conclusions Efavirenz concentrations increased steadily over 48 weeks, and a substantial proportion of participants had efavirenz C 12 above the upper limit of the proposed therapeutic window, especially those with low body weight (< 60 kg). Based upon these findings, a dosage reduction of efavirenz to 400 mg daily may warrant consideration in this population, especially for those with lower body weight.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.084
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.301
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations22
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueHIV MedicineSame topicHIV/AIDS drug development and treatmentFrench-language works237,207